RNA-seq data are invariably associated with clinical outcomes of interest, such as disease status, response to treatment, disease sub-type, quantitative phenotypic traits or information on time to an event of interest (e.g. survival, complication, metastasis). Using modern statistical methods, we can identify (bio)signatures which can help to gain intuition into the molecular mechanisms of disease, identify drug targets, or design new diagnostic assays.
